23 hrs ago
Solta Medical Downgraded by Raymond James to Market Perform
They currently have a $3.00 price objective on the stock. Raymond James' target price indicates a potential upside of 2.74% from the stock's previous close.
Attention SLTM Shareholders: The Proposed Buyout of Solta Medical,...
The Young Law Firm , a national shareholder litigation firm, is investigating potential claims concerning the proposed acquisition of Solta Medical, Inc by Valeant Pharmaceuticals International, Inc .
TrendingWallStreet.com Begins Analytical Coverage on SLTM, OLIE, XOM, ...
Solta Medical, Inc. shares closed up 39.71 percent on Monday with about 28 million shares traded.
Mon Dec 16, 2013
Mid-Afternoon Market Update: Markets Rise as Twitter Pulls Back
Toward the end of trading Monday, the Dow traded up 0.85 percent to 15,889.77 while the NASDAQ surged 0.72 percent to 4,029.60.
Deals, data drive Toronto upward
Valeant, BlackBerry dominate The Toronto stock market registered a solid advance Monday amid strong manufacturing data from the United States and Europe and major corporate acquisitions.
Stocks to Track - Solta Medical Inc (NASDAQ:SLTM), Himax...
Micro caps are companies with a capitalization between $50 million and $300 million.
Valeant Pharmaceuticals International Takes Over Solta Medical, Inc. For $250 Million Cash
The transaction is expected to close in the first quarter of 2014 and Valeant expects the transaction, once completed, to be immediately accretive to Valeant's cash earnings per share.
Tue Dec 03, 2013
Worth Watching Stocks - Solta Medical Inc (NASDAQ:SLTM), Fresh...
Value Stock Pick is a leading Investment Newsletter. Our Research Team conducts research on different stocks, doing their due diligence to provide a detailed report, including both technical and fundamental analysis, on NYSE, NASDAQ, AMEX, OTCBB and Pink Sheet Stocks.
Wed Nov 20, 2013
Solta Medical sets up $60 million credit deal
Solta Medical Inc. made a deal to borrow up to $60 million at an interest rate of 13.5 percent per year.